Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125122) titled 'Effects of an Internet-Based Comprehensive Self-Management Platform on Disease Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial with Qualitative Process Evaluation' on May 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Irritable Bowel Syndrome (IBS)
Intervention:
Intervention group:A comprehensive self-management intervention platform, comprising the WeChat public account "Chang Lai Chang Wang" with an embedded WeChat mini-program "Chang Lai Guan Li"
Recr...